Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement

OBJECTIVE: This research assesses the impact of an outcome-based payment arrangement (OBA) linking complete remission (CR) to survival as a means of maintaining cost-effectiveness for a chimeric antigen receptor T cell (CAR-T) therapy in young patients with acute lymphoblastic leukemia (ALL). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Gye, Amy, Goodall, Stephen, De Abreu Lourenco, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883311/
https://www.ncbi.nlm.nih.gov/pubmed/36266557
http://dx.doi.org/10.1007/s40273-022-01188-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883311/
https://www.ncbi.nlm.nih.gov/pubmed/36266557
http://dx.doi.org/10.1007/s40273-022-01188-w

Ejemplares similares